These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19288694)

  • 1. [Preventive cardiovascular recommendations].
    Maiques Galán A; Villar Alvarez F; Brotons Cuixart C; Torcal Laguna J; Orozco-Beltrán D; Navarro Pérez J; Lobos-Bejarano JM; Banegas Banegas JR; Ortega Sánchez-Pinilla R; Gil Guillén V; Solana Saura P;
    Aten Primaria; 2007 Nov; 39 Suppl 3():15-26. PubMed ID: 19288694
    [No Abstract]   [Full Text] [Related]  

  • 2. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural antioxidant compounds in risk factors for CVD.
    Kaliora AC; Dedoussis GV
    Pharmacol Res; 2007 Aug; 56(2):99-109. PubMed ID: 17572098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence.
    Foody JM; Benner JS; Frishman W
    J Clin Hypertens (Greenwich); 2007 Apr; 9(4):271-5. PubMed ID: 17396070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Other antihyperuricemic agents].
    Ogino K; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular preventive activities in primary care].
    Villar Alvarez F; Maiques Galán A; Brotons Cuixart C; Torcal Laguna J; Ortega Sánchez-Pinilla R; Vilaseca Canals J; Forés García D; Banegas Banegas JR; Lobos Bejarano JM; Orozco Beltrán D; Gil Guillén VF; Llor Vila C; Lorenzo Piqueres A; Navarro Pérez J
    Aten Primaria; 2003 Dec; 32 Suppl 2():15-29. PubMed ID: 15116471
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggressive lipid, hypertension targeting yields no benefit for some with diabetes.
    Mitka M
    JAMA; 2010 May; 303(17):1681-3. PubMed ID: 20442377
    [No Abstract]   [Full Text] [Related]  

  • 8. Taking risks: primary prevention of cardiovascular events.
    Vallance P
    N Z Med J; 2001 May; 114(1132):223-4. PubMed ID: 11453356
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations of the second Indo-U.S. health summit on prevention and control of cardiovascular disease among Asian Indians.
    Enas EA; Singh V; Munjal YP; Gupta R; Patel KC; Bhandari S; Agarwal AK; Joshi SR; Anoop M; Prabhakaran D; Shah B; Reddy S; Sharma B; Trehan N; Yavagal ST; Kasliwal RR;
    Indian Heart J; 2009; 61(3):265-74. PubMed ID: 20503833
    [No Abstract]   [Full Text] [Related]  

  • 10. Fixed drug combination in hypertension and hyperlipidaemia in the developing world.
    Seedat YK
    Cardiovasc J Afr; 2008; 19(3):124-6. PubMed ID: 18568170
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 12. Severely frail elderly patients do not need lipid-lowering drugs.
    Mallery LH; Moorhouse P; McLean Veysey P; Allen M; Fleming I
    Cleve Clin J Med; 2017 Feb; 84(2):131-142. PubMed ID: 28198686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor?
    Rabelink TJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):23-6. PubMed ID: 14671033
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiovascular risk profile and anti-hypertensive treatment].
    Olsen MH; Sehestedt T; Prescott E
    Ugeskr Laeger; 2009 Jun; 171(24):2008-11. PubMed ID: 19523363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy: ACCORD Blood Pressure and ACCORD Lipid: how low can we go?
    Glandt M; Raz I
    Nat Rev Endocrinol; 2010 Sep; 6(9):483-4. PubMed ID: 20720591
    [No Abstract]   [Full Text] [Related]  

  • 16. Medications and cardiovascular health in older adults: room for improvement in prevention and treatment.
    Rhoads CS; Psaty BM; Olson JL; Furberg CD
    Am J Geriatr Cardiol; 2004; 13(3):161-7. PubMed ID: 15133419
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypertension and hyperlipidemia].
    Hansen HS; Larsen ML
    Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOPE-‑3, BP treatment, milestones in CV prevention. Dr. Salim Yusuf in an interview with Dr. Akbar Panju and Dr. Roman Jaeschke.
    Yusuf S; Panju A; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1033-1035. PubMed ID: 28010010
    [No Abstract]   [Full Text] [Related]  

  • 19. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 20. Triggering of acute cardiovascular disease and potential preventive strategies.
    Tofler GH; Muller JE
    Circulation; 2006 Oct; 114(17):1863-72. PubMed ID: 17060396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.